Approval · Notice of Compliance 26171 · 2021
NEXHA: Notice of Compliance 26171
Issued June 29, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26171
- Date
- June 29, 2021
- Company
- Vetoquinol N A IncLavaltrie, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug product manufacturing site; Changes to shelf life
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEXHA | 02375176 | Marketed |
Medicinal ingredients
- HYALURONATE SODIUM 10 MG per ML